Autopsy report · NCT01337414

Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)

“Lack of financial support”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months after it had already started.
• Ran for about 4 years 11 months before it stopped.
• 324 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Age-related Macular Degeneration

Interventions

VMS diary booklet; Standard of Care

Participants

324

Sites

1

Countries

United States

Trials that died the same way

• Impact of Surgical Theater's Patient Engagement
  “Lack of support/funding” (86% match in meaning)
• ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases
  “no financial support” (86% match in meaning)
• Effects of Empowerment-based Program on Post-discharge Glycemic Control, and Foot Ulcer
  “Lack of financial resources” (82% match in meaning)
• Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer
  “No financial support aproved” (80% match in meaning)
• Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
  “Lack of financial support and low inclusion rate” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.